1. Home
  2. FPF vs COLL Comparison

FPF vs COLL Comparison

Compare FPF & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPF
  • COLL
  • Stock Information
  • Founded
  • FPF 2013
  • COLL 2002
  • Country
  • FPF United States
  • COLL United States
  • Employees
  • FPF N/A
  • COLL N/A
  • Industry
  • FPF Trusts Except Educational Religious and Charitable
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • FPF Finance
  • COLL Health Care
  • Exchange
  • FPF Nasdaq
  • COLL Nasdaq
  • Market Cap
  • FPF 1.1B
  • COLL 1.1B
  • IPO Year
  • FPF N/A
  • COLL 2015
  • Fundamental
  • Price
  • FPF $18.65
  • COLL $33.35
  • Analyst Decision
  • FPF
  • COLL Strong Buy
  • Analyst Count
  • FPF 0
  • COLL 5
  • Target Price
  • FPF N/A
  • COLL $43.80
  • AVG Volume (30 Days)
  • FPF 186.7K
  • COLL 486.5K
  • Earning Date
  • FPF 01-01-0001
  • COLL 02-20-2025
  • Dividend Yield
  • FPF 8.08%
  • COLL N/A
  • EPS Growth
  • FPF N/A
  • COLL 757.11
  • EPS
  • FPF N/A
  • COLL 2.16
  • Revenue
  • FPF N/A
  • COLL $599,245,000.00
  • Revenue This Year
  • FPF N/A
  • COLL $13.20
  • Revenue Next Year
  • FPF N/A
  • COLL $17.63
  • P/E Ratio
  • FPF N/A
  • COLL $15.42
  • Revenue Growth
  • FPF N/A
  • COLL 9.62
  • 52 Week Low
  • FPF $13.91
  • COLL $28.39
  • 52 Week High
  • FPF $18.09
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • FPF 62.48
  • COLL 62.31
  • Support Level
  • FPF $17.90
  • COLL $32.29
  • Resistance Level
  • FPF $18.77
  • COLL $33.99
  • Average True Range (ATR)
  • FPF 0.19
  • COLL 1.29
  • MACD
  • FPF 0.09
  • COLL 0.51
  • Stochastic Oscillator
  • FPF 88.78
  • COLL 87.40

About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: